VeinViewer is the only device of its kind clinically proven to improve the patient experience and impact the quality of care when inserting peripheral IVs
MEMPHIS, Tennessee (PRWEB) May 12, 2016
Christie Medical Holdings, a global leader in near infrared vein finding technology, will be showcasing VeinViewer® Vision2 and VeinViewer Flex at the Infusion Nurses Society (INS) 2016 annual conference.
VeinViewer by Christie reduces the time needed to place an IV catheter and improves first-stick success rates by up to 100 percent. VeinViewer technology uses near infrared light to create a real-time high definition image of patient veins projected directly on the skin. VeinViewer also lets clinicians see valves and bifurcations, which aids in pre-stick decision making for the point of insertion. In post-assessment procedures, clinicians can assess the patency of the vessel to help avoid complications. The use of VeinViewer helps hospitals meet the guidelines for patient care and safety laid out by the INS.
In its recently released Infusion Therapy Standards of Practice, INS recommends that vascular visualization technology be used to increase success with venipuncture and decrease the need for central vascular access device insertion. Additionally, INS calls for the use of vein visualization technology, including near infrared light technology, by clinicians for patients with difficult venous access or after failed venipuncture attempts.
“VeinViewer is the only device of its kind clinically proven to improve the patient experience and impact the quality of care when inserting peripheral IVs,” says George Pinho, president, Christie Medical Holdings. “In light of the recently updated Standards of Practice by the INS that highlights the benefits of vein visualization technology, we’re excited to demonstrate VeinViewer at INS 2016 so clinicians can see firsthand the positive impact our technology has on venous access and patient care.” Christie Medical Holdings will be at INS 2016 at the Greater Fort Lauderdale-Broward County Convention Center, Florida, in booth 703, from May 16-18.
To learn more about Christie VeinViewer Vision2 and VeinViewer Flex, please visit http://www.christiemed.com.
About Christie Medical Holdings, Inc.
Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is manufactured in the USA. It is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit http://www.christiemed.com.
For cautions associated to Christie Medical Holdings products, please visit http://www.christiemed.com/cautions.
Follow us on Twitter @christiemed
“Christie” is a trademark of Christie Digital Systems USA, Inc., registered in the United States of America and certain other countries.